Triple Negative Metastatic Breast Cancer
Also known as: Metastatic Triple Negative Breast Cancers / Triple Negative Breast Cancer Metastatic / Triple-negative Metastatic Breast Cancer / Metastatic Breast Cancer, Triple Negative Breast Cancer / Metastatic Triple-negative Breast Cancer / Metastatic Triple Negative Breast Cancer / Metastatic Triple-Negative Breast Carcinoma / Triple negative malignant neoplasm of breast (disorder) / Triple Negative Breast Neoplasms / Triple negative breast cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |
DB12893 | Sacituzumab govitecan | Sacituzumab govitecan targets TROP-2-expressing cancer cells through a humanized antibody (RS7) before subsequently becoming internalized and releasing the topoisomerase I inhibitor SN-38 to induce DNA damage-mediated apoptosis. |